Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01748162 · ClinicalTrials.gov registry record · Phase 3
Management of Recurrent Croup
A Phase 3 study, sponsored by University of Michigan.
- Terminated
- Registry status
- Phase 3
- Development phase
- 10
- Enrollment target
NCT01748162 is a Phase 3 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 10 participants.
The verdict
NCT01748162, a Phase 3 study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 10 participants
- Enrollment target
Study Summary
Presently children who experience recurring croup symptoms receive a variety of treatments. This is because it is not clear which treatments may be best. Some children are given inhaled steroids (similar to what children with asthma use). Others are carefully watched and cautioned to avoid potential triggers (certain foods, environmental allergens, etc), and should episodes of croup recur they are treated with a short course of oral steroids. The purpose of this study is to compare two safe and clinically appropriate methods for treating recurrent croup, daily inhaled steroids versus observation with oral steroids on an as needed basis, to see if either is useful in preventing future episodes of croup.
Interventions
- DRUG Fluticasone
- DRUG Prednisolone IF needed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-09 |
| Est. Completion | 2014-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01748162
The ClinicalTrials.gov registry entry for NCT01748162 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fluticasone is the first listed.
NCT01748162 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01748162 about?
NCT01748162 is a clinical study titled "Management of Recurrent Croup". Presently children who experience recurring croup symptoms receive a variety of treatments. This is because it is not clear which treatments may be best. Some children are given inhaled steroids (similar to what children with asthma use). Others are carefully watched and cautioned to avoid potential...
What is the current status of trial NCT01748162?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2012-09. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01748162?
The interventions under investigation include: Fluticasone (DRUG), Prednisolone IF needed (DRUG).
Who is sponsoring clinical trial NCT01748162?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.